keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
Published 3 years ago • 413 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
3:14
keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...
-
1:25
dr. davis on caveats of the keynote-062 trial findings in gastric/gej cancer
-
1:47
quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal juncti...
-
1:54
pembrolizumab in advanced gastric cancer treatment
-
8:25
pembrolizumab comparable to chemotherapy for patients with advanced gastric or gastroesophageal ...
-
1:56
josep tabernero, md, phd, offers perspective on keynote-062 in advanced gastroesophageal
-
0:46
microsatellite instability serves as a predictive biomarker of response to pembrolizumab
-
3:52
systemic therapy in pd-l1–positive gastric cancer
-
1:35
clinical outcomes for the treatment of pembrolizumab in patients with advanced gastric cancer
-
0:58
significance of keynote-045 trial of pembrolizumab vs chemotherapy in urothelial carcinoma
-
1:33
efficacy and safety results for pembrolizumab in previously treated gastric cancer
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
6:19
immunotherapy in advanced/metastatic gastric/gej cancers
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer